[1]兰菊,阮俊霖,王世栋.降脂化浊汤配合循经推拿治疗痰湿型非酒精性脂肪性肝病疗效观察[J].西部中医药,2026,39(02):178-181.[doi:10.12174/j.issn.2096-9600.2026.02.35]
 LAN Ju,RUAN Junlin,WANG Shidong.Clinical Observation on Lipid-lowering Turbidity-resolving Decoction Joined with Massage along Meridians in the Treatment of Non-alcoholic Fatty Liver Diseases with Phlegm-dampness Pattern[J].Western Journal of Traditional Chinese Medicine,2026,39(02):178-181.[doi:10.12174/j.issn.2096-9600.2026.02.35]
点击复制

降脂化浊汤配合循经推拿治疗痰湿型非酒精性脂肪性肝病疗效观察()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
39
期数:
2026年02期
页码:
178-181
栏目:
特色医疗
出版日期:
2026-02-15

文章信息/Info

Title:
Clinical Observation on Lipid-lowering Turbidity-resolving Decoction Joined with Massage along Meridians in the Treatment of Non-alcoholic Fatty Liver Diseases with Phlegm-dampness Pattern
作者:
兰菊, 阮俊霖, 王世栋
南宁市第二人民医院,广西 南宁 530031
Author(s):
LAN Ju, RUAN Junlin, WANG Shidong
The Second Nanning People’s Hospital, Nanning 530031, China
关键词:
脂肪性肝病非酒精性降脂化浊汤循经推拿痰湿证氧化应激
Keywords:
fatty liver disease non-alcoholiclipid-lowering turbidity-resolving decoctionmassage along meridiansphlegm-dampness patternoxidative stress
分类号:
R256.4
DOI:
10.12174/j.issn.2096-9600.2026.02.35
文献标志码:
B
摘要:
目的观察降脂化浊汤配合循经推拿治疗痰湿型非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的临床疗效。 方法选择72例痰湿型NAFLD患者,按照治疗方法的不同分为对照组与治疗组,每组36例。两组均根据指南予非药物干预措施,对照组予阿托伐他汀钙片口服治疗,治疗组予降脂化浊汤配合循经推拿治疗,两组均连续治疗4周。比较两组治疗前后生化指标[谷草转氨酶(aspartate aminotransferase,AST)、丙氨酸转氨酶(alanine aminotransferase,ALT)、总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)]、氧化应激指标[血清超氧化物歧化酶(superoxide dismutase,SOD)、谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-Px)、总抗氧化能力(total antioxidant capacity,T-AOC)]及痰湿证单项症状评分的变化情况和临床疗效。 结果治疗后,两组患者血清AST、ALT、TC、TG水平均降低(P<0.05),SOD、GSH-Px、T-AOC水平均升高(P<0.05),痰湿证单项症状评分均减少(P<0.05);且治疗组上述指标改善程度均大于对照组(P<0.05)。总有效率治疗组[94.44%(34/36)]高于对照组[72.22%(26/36)](P<0.05)。 结论降脂化浊汤配合循经推拿治疗痰湿型NAFLD疗效确切,能够抑制氧化应激反应,改善患者肝功能,调节血脂水平,改善临床症状。
Abstract:
ObjectiveTo observe clinical effects of lipid-lowering turbidity-resolving decoction and massage along meridians in the treatment of NAFLD with phlegm-dampness pattern. MethodsAll 72 patients were selected, and allocated to the control group and the treatment group in light of different therapeutic methods with 36 cases in each group. Both groups accepted non-pharmacological interventions according to the guideline, the control group took atorvastatin calcium tablets orally, while lipid-lowering turbidity-resolving decoction and massage along meridians were given to the treatment group, and both groups were treated for four weeks continuously. To compare biochemical indicators including AST, ALT, TC and TG, oxidative stress indicators containing SOD, GSH-Px and T-AOC, single symptom score for phlegm-dampness pattern, together with curative effects before and after the treatment in the two groups. ResultsAfter the treatment, the decrease in the levels of AST, ALT, TC and TG was found in the two groups (P<0.05), the levels of SOD, GSH-Px and T-AOC were increased (P<0.05), and single symptom score for phlegm-dampness pattern were reduced (P<0.05); and the improvements of the above indexes in the treatment group were greater than these of the control group (P<0.05). Total effective rate of the treatment group was [94.44%(34/36)], higher than [72.22%(26/36)] of the control group (P<0.05). ConclusionLipid-lowering turbidity-resolving decoction and massage along meridians demonstrates definite clinical effects in the treatment of NAFLD with phlegm-dampness pattern, it could inhibit oxidative stress response, enhance liver function, regulate the levels of blood lipid and improve clinical symptoms.

相似文献/References:

[1]王磊.泽泻饮合京三棱丸治疗非酒精性脂肪肝34例[J].西部中医药,2013,26(09):64.
 WANG Lei.ZeXie Drink and Jing SanLengWan in Treating 34 Cases of Non Alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(02):64.
[2]王晋阳,杨少军△,井小会.中医药化浊降脂法治疗非酒精性脂肪肝的研究进展*[J].西部中医药,2015,28(02):132.
[3]陈芳玉,张杰,毛莲香,等.疏肝健脾化痰汤治疗非酒精性脂肪性肝炎50例[J].西部中医药,2015,28(06):94.[doi:2015/6/16 0:00:00]
[4]江明洁,贺劲松△.“三因制宜”理论辨治非酒精性脂肪性肝病[J].西部中医药,2018,31(10):22.
 JIANG Mingjie,HE Jinsong.Differentiating and Treating Non-alcoholic Fatty Liver Disease by the Theory of “Treatment Individualized to Patient, Season and Locality”[J].Western Journal of Traditional Chinese Medicine,2018,31(02):22.
[5]张玉香,王一强,姜德民,等.清肝祛湿活血方对非酒精性脂肪肝大鼠肿瘤坏死因子α及肝脏组织的影响[J].西部中医药,2018,31(08):13.
 ZHANG Yuxiang,WANG Yiqiang,JIANG Demin,et al.Effects of Liver-clearing Dampness-removing Blood Circulation-promoting Prescription on Liver Tissue and TNF-α of the Rats with Non-alcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(02):13.
[6]吴海滨,林基伟,宋晓容,等.基于PI3K/AKT/Foxo1信号通路探讨大黄素防治非酒精性脂肪肝的作用机制[J].西部中医药,2025,38(07):18.[doi:10.12174/j.issn.2096-9600.2025.07.04]
 WU Haibin,LIN Jiwei,SONG Xiaorong,et al.Emodin Prevents and Treats NAFLD via PI3K/AKT/Foxol Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2025,38(02):18.[doi:10.12174/j.issn.2096-9600.2025.07.04]
[7]陶庆,蓝健姿,曹建红,等.东方肝康口服液治疗非酒精性脂肪性肝病疗效观察[J].西部中医药,2019,32(07):1.
 TAO Qing,LAN Jianzi,CAO Jianhong,et al.Clinical Observation on DongFang GanKang Oral Liquid in the Treatment for Nonalcoholic Fatty Liver Disease[J].Western Journal of Traditional Chinese Medicine,2019,32(02):1.
[8]姜慧,李军祥,谭祥,等.基于网络药理学和分子对接探讨健脾疏肝方治疗非酒精性脂肪性肝病的作用机制[J].西部中医药,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]
 JIANG Hui,LI Junxiang,TAN Xiang,et al.The Mechanism of Invigorating-spleen Soothing-liver Prescription in the Treatment of Non-alcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(02):83.[doi:10.12174/j.issn.2096-9600.2024.02.17]
[9]梁淑芳,黄国开,聂姝常,等.薯蓣皂苷元对非酒精性脂肪性肝病小鼠脂质代谢的影响[J].西部中医药,2025,38(02):6.[doi:10.12174/j.issn.2096-9600.2025.02.02]
 LIANG Shufang,HUANG Guokai,NIE Shuchang,et al.Impacts of Diosgenin on Lipid Metabolism in Non-alcoholic Fatty Liver Disease Mice[J].Western Journal of Traditional Chinese Medicine,2025,38(02):6.[doi:10.12174/j.issn.2096-9600.2025.02.02]
[10]谢文涛,王睿,席菲菲.自拟清肝降脂汤治疗非酒精性脂肪性肝病肝郁脾虚证疗效观察[J].西部中医药,2025,38(09):108.[doi:10.12174/j.issn.2096-9600.2025.09.19]
 XIE Wentao,WANG Rui,XI Feifei.Clinical Observation on Selfmade Liver-clearing Lipid-lowering Decoction in the Treatment of NAFLD of Liver-Qi Stagnation and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2025,38(02):108.[doi:10.12174/j.issn.2096-9600.2025.09.19]

备注/Memo

备注/Memo:
广西壮族自治区中医药管理局自筹经费科研课题(GXZYZ20210128)。兰菊(1980—),女,主任医师。研究方向:中西医结合临床与不孕不育研究。Email:525210941@qq.com。
更新日期/Last Update: 2026-02-15